Purpose
The purpose of the Drug Compounding Interest Group (IG) is to bring together industry leaders involved in 503A and 503B Drug Compounding facilities. Professionals openly discuss their issues and concerns about emerging regulations, best practices, and navigating the landscape of compliance. Discussion topics also include production techniques, personnel practices, facility management, control of materials, and application of GMPs in daily operations, ensuring quality for all drug products. The FDA Compounding Quality Center of Excellence participates in the group, but this forum is not used to discuss any policy issues or direct specific questions to the FDA. This group and all other PDA Interest Groups are designed to spark information exchange, actionable solutions and networking among peers who have shared challenges and interests.
- Click the “Join this Interest Group” button below and click the “Join” button for the IGs you wish to receive communications from regarding virtual meetings, special events, and volunteer opportunities.
- The Interest Group LinkedIn Group is open to anyone interested in the topics and provides an online venue to meet experts and to engage in group discussions and learn about valuable PDA resources. Click the “Follow Discussion” button below and request to join.
- Virtual and in-person meetings are scheduled throughout the year. Virtual meetings are exclusively for active PDA members. In-person meetings, often held in conjunction with PDA’s signature conferences, are open to any conference attendee.
